Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
about
Hybridization interactions between probesets in short oligo microarrays lead to spurious correlationsThe insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcomaLIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcriptionThe promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cellsRapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingUncovering the complexities of Kaposi's sarcoma through genome-wide expression analysisA molecular map of mesenchymal tumors.KSHV-Mediated Angiogenesis in Tumor ProgressionOncogenes and RNA splicing of human tumor virusesTumor endothelial cellsHost epigenetic modifications by oncogenic virusesThe ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirusHsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteinsLymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activityEndothelial cell heterogeneityAngiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated HerpesvirusRemodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis.Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.The AIDS and Cancer Specimen Resource: role in HIV/AIDS scientific discovery.Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.Signature Evaluation Tool (SET): a Java-based tool to evaluate and visualize the sample discrimination abilities of gene expression signaturesEndothelial cells support persistent gammaherpesvirus 68 infection.A novel regulatory event-based gene set analysis method for exploring global functional changes in heterogeneous genomic data sets.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells.KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endotheliaIncreased epithelial stem cell traits in advanced endometrial endometrioid carcinoma.Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.An in vitro system for studying murid herpesvirus-4 latency and reactivation.Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature.Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expressionKaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells
P2860
Q21284255-05716E47-ECA3-4ECE-A326-138FE405DFCAQ24304458-DA4704E2-0332-41D5-AAB0-75320D76F220Q24314650-472A9F46-16D1-4875-AD52-68136A100FF5Q24532969-CFB94A67-32F7-4818-8593-2A27276B42E9Q24629364-D83E5AF1-2A32-4F35-9898-86E3618A0CD5Q24673299-511BD158-B06E-490D-BF8D-AB5A804582F0Q24809576-D832AB31-CE6F-4FC0-AE60-7645424A6A53Q24814030-B071CA41-6E13-44A4-9340-E1A3F374F94DQ26742030-CDAAECF6-445A-44F4-9194-48C884E7E514Q26830643-69F27F14-31AF-4BEC-9481-0945A49D7307Q26995733-DE9351AB-2F0E-42F9-877F-6248E32CFAADQ27485909-5EA0BBE6-4AC8-44E4-AA64-4C7A969DD847Q28267511-CC8DCC19-7D8E-49C3-9136-482EB918E470Q28485399-D6B57A2E-B227-4211-8C4C-9D987AAAF9D5Q28584887-7F5322F7-0782-4BF2-8FCA-8D0C89B64509Q28740296-E438177F-3CD6-42EC-A1FA-686A3CAD3168Q28750291-38EECA96-6F92-4D18-BF55-C6FC77D61082Q30439948-DF2A896C-065F-4A1A-82CA-1648D5B28141Q31133087-5F46B816-83DE-46F5-B27C-73B3E11D0B8FQ31160132-01EBA0EE-6E1A-4B0F-8EEA-9AB3681C1127Q33276685-D19C134B-0197-45D3-84D0-50B4634A8BBFQ33301012-EE9BE5C6-CA4D-454E-BB95-9CFCF0E86BE2Q33316593-CA51CF6F-CEBD-4DB0-B03D-0DC9C0C21C99Q33369078-C9715E1F-C31E-4254-8B13-F71D1FF62882Q33400135-3AAD481F-DCC5-4DA8-99DB-38C13DBD16D2Q33432690-8F1E379A-23C3-4655-93C9-ADE2A5D54A3FQ33491306-8A3AB182-0EA9-434B-90F5-14A0AECA061FQ33509506-2198F5EA-462D-409B-868E-DB8BB934EF5EQ33518922-A4EDED80-105F-4725-A1FF-EDE085778BE9Q33533675-DEAF5D7D-8AEF-4589-9104-FCCD293B8634Q33560572-AD1656DA-320A-4EDD-9C11-9E0AE91014F8Q33605765-A0DAEC5E-1BC3-4C41-975B-5F5B97323C84Q33618560-7409EC07-36EB-43FB-BA93-D8A89D93F92DQ33667093-0BEE8C78-FF29-456D-AB85-2ECB87AC33D9Q33668719-B1D69942-BFB2-4897-9466-77210411C158Q33761091-21F2F27B-4BAD-4E14-92C1-465BC8DFBFF4Q33793543-BE1F2076-E6F4-4C74-8531-9C9DDF6F7B43Q33825706-1F5D641A-AE3E-4279-AE59-DFACF8F23A64Q33882749-19CF15F0-D3D6-430A-A4C1-7B16D4441C4FQ33997193-D2A5C056-9021-48B9-BD9F-85C4D64087B3
P2860
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@ast
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@en
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@nl
type
label
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@ast
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@en
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@nl
prefLabel
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@ast
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@en
Kaposi sarcoma herpesvirus-ind ...... expression in Kaposi sarcoma.
@nl
P2093
P50
P356
P1433
P1476
Kaposi sarcoma herpesvirus-ind ...... e expression in Kaposi sarcoma
@en
P2093
Adrienne M Flanagan
Chris Boshoff
Dimitra Bourboulia
Hsei-Wei Wang
Matthew W B Trotter
Stephen Elliman
Taija Mäkinen
P2888
P304
P356
10.1038/NG1384
P407
P577
2004-06-27T00:00:00Z